These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18382260)

  • 1. Electrocardiographic evaluation of cardiovascular status.
    Wung SF; Kozik T
    J Cardiovasc Nurs; 2008; 23(2):169-74. PubMed ID: 18382260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS; Selvaraj RJ
    Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterogeneities of ventricular repolarization and vulnerability to arrhythmia. How to detect them with noninvasive methods?].
    De Ambroggi L
    Cardiologia; 1999 Apr; 44(4):355-60. PubMed ID: 10371787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The microvolt T-wave alternans test].
    Görmez S; Erciyes D; Gülbaran M
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):436-43. PubMed ID: 21200127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
    J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diastolic micropotentials in high-resolution surface ECG in QT syndrome].
    Eggeling T; Höpp HW; Schickendantz S; Osterspey A; Mennicken U; Hombach V; Hilger HH
    Z Kardiol; 1986 Jul; 75(7):410-6. PubMed ID: 3765764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
    Chow T; Joshi D
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic arrhythmia risk testing.
    Engel G; Beckerman JG; Froelicher VF; Yamazaki T; Chen HA; Richardson K; McAuley RJ; Ashley EA; Chun S; Wang PJ
    Curr Probl Cardiol; 2004 Jul; 29(7):365-432. PubMed ID: 15192691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic predictors of sudden cardiac death.
    Carey MG
    J Cardiovasc Nurs; 2008; 23(2):175-82. PubMed ID: 18382261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological detection algorithms for the automatic implantable cardioverter/defibrillator (AICD).
    Kaup HJ; Hexamer M; Werner J
    Biomed Tech (Berl); 2004 Nov; 49(11):306-10. PubMed ID: 15624867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.
    Haghjoo M; Arya A; Sadr-Ameli MA
    Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T wave alternans: a marker of myocardial instability.
    Harvey M; Malkin R
    Prog Cardiovasc Nurs; 2003; 18(2):99-107, 111. PubMed ID: 12732803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.
    Divekar A; Soni R
    Pediatrics; 2006 Aug; 118(2):e526-9. PubMed ID: 16816007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death: the role of risk stratification.
    Kusmirek SL; Gold MR
    Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for implantable cardioverter defibrillators in long QT syndrome?
    Welde AA
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1 Suppl):S110-3. PubMed ID: 11852886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate ventricular tachycardia after abnormal microvolt T-wave alternans.
    Sedkowska A; Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Kalarus Z
    Cardiol J; 2009; 16(4):365-7. PubMed ID: 19653182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.